December 20, 2024

Bio-interventional Cyclodialysis with Allograft Scleral Reinforcement for OAG

The combined procedure decreased IOP and improved BCVA.

Conexiant

December 20, 2024

Workplace Discrimination in Ophthalmology

“Your husband also works, so you’re the second income.’”

Conexiant

December 17, 2024

Objective Perimetry More Sensitive than Standard Automated Perimetry

Study finds multifocal pupillographic objective perimetry is a faster, more reliable approach to glaucoma diagnostics compared to standard automated perimetry.

Conexiant

December 16, 2024

Does Ozempic Double Eye Disease Risk?

Danish health authorities seek EU review of studies linking Novo Nordisk's Ozempic to rare eye condition in type 2 diabetes patients.

Reuters

December 11, 2024

Polygenic Risk Scores Predict Glaucoma Risk Stratification

Even before a clinical manifestation of glaucoma, risk stratification can be achieved through intraocular pressure and vertical cup-disc ratio polygenic risk scores.

Conexiant

December 05, 2024

Ex-Eye Bank Workers Say Pressure, Lax Oversight Led to Errors

Former employees reveal the challenges and ethical concerns surrounding the procurement of eye tissue and corneas in Wyoming and Colorado, shedding light on the need for improved oversight and industry standards.

KFF Health News

December 03, 2024

Novel Eye Perfusion Model Advances Retinal Disease Research

Innovative perfusion techniques recreate physiological conditions in the retina, offering a powerful tool for studying blindness and eye diseases.

Conexiant

December 02, 2024

Myopia Interventions Ranked by Efficacy

Interventions in childhood, “have the potential to reduce future visual impairment."

Conexiant

March 01, 2023

Treatment of Severe Ocular Surface Disease in the Glaucoma Patient

PentaVision is an independent company dedicated to eye care professionals. More about our magazines, newsletters, conferences, education and other services at pentavisionmedia.com.

Glaucoma Physician